4Filing Date: Dec 23, 2025

Hims & Hers Health

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001773751-25-000390
Total Value$824.7K
Trades2
Insiders1

Transaction Details

Okupe Oluyemi
Chief Financial Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-23.09K
Price$35.72
Total Value$824.7K
Shares Owned After94.33K
Transaction DateDec 22, 2025
10b5-1
Footnotes ▸

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.36-35.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Okupe Oluyemi
Chief Financial Officer·Indirect · Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Class A Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.85K
10b5-1Holding Only

Post-Transaction Holdings

Okupe Oluyemi · Chief Financial Officer
SecuritySharesChange
Class A Common Stock102.19K-23.09K (-18.43%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2025-12-22 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2025-12-22 | Code: S (Open market sale) Shares: -23,090 | Price: $35.72 Total Value: $824,710.15 Shares Owned After: 94,333 | Ownership: D (Direct) Footnotes: [F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F2] Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.36-35.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $35.36-35.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2025-12-23)

keid analysis is for reference only and does not constitute investment advice.